Multicentre cohort study to define and validate pathological assessment of response to neoadjuvant therapy in oesophagogastric adenocarcinomaFergus Noble, Jamie Kelly, Tim Underwood et al.|British journal of surgery|2017Cited by 108
Patient-specific cancer genes contribute to recurrently perturbed pathways and establish therapeutic vulnerabilities in esophageal adenocarcinomaThanos P. Mourikis, Shaun R. Preston, Lorena Benedetti et al.|Nature Communications|2019Cited by 49
Whole-genome sequencing of nine esophageal adenocarcinoma cell linesGianmarco Contino, Rebecca C. Fitzgerald, Matthew Eldridge et al.|F1000Research|2016Cited by 33
Authentication and characterisation of a new oesophageal adenocarcinoma cell line: MFD-1Edwin Garcia, Annette Hayden, Charles N. Birts et al.|Scientific Reports|2016Cited by 24
Author Correction: Authentication and characterisation of a new oesophageal adenocarcinoma cell line: MFD-1Edwin Garcia, Richard Turkington, Annette Hayden et al.|Scientific Reports|2019Cited by 2